Ftse Mib
33.771,75
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
58.812,91
0,99%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Circio Holding Asa (0RIS) Circio Holding Asa (0RIS) Notizie

0RIS

Circio Holding Asa (0RIS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RIS
DataOraFonteTitoloSimboloCompagnia
28/02/202207:28PR Newswire (US)Targovax ASA strengthens management with Lubor Gaal as Chief Financial OfficerLSE:0RISCircio Holding Asa
12/01/202212:11PR Newswire (US)Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation NorwayLSE:0RISCircio Holding Asa
20/12/202108:17PR Newswire (US)Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesotheliomaLSE:0RISCircio Holding Asa
04/11/202107:35PR Newswire (US)Targovax ASA: Third quarter 2021 resultsLSE:0RISCircio Holding Asa
25/10/202113:48PR Newswire (US)Targovax: Presentation material for today's webcastLSE:0RISCircio Holding Asa
20/10/202108:50PR Newswire (US)Targovax ASA appoints Dr. Erik Digman Wiklund as new CEOLSE:0RISCircio Holding Asa
19/10/202114:27PR Newswire (US)Targovax to present at upcoming conferencesLSE:0RISCircio Holding Asa
06/10/202115:00PR Newswire (US)Targovax ASA: Two abstracts accepted at the SITC CongressLSE:0RISCircio Holding Asa
30/09/202107:49PR Newswire (US)Targovax ASA appoints Ola Melin as Head of ManufacturingLSE:0RISCircio Holding Asa
24/09/202111:19PR Newswire (US)Targovax granted European Patent for ONCOS-102 in combination with chemotherapyLSE:0RISCircio Holding Asa
16/09/202107:42PR Newswire (US)Targovax ASA: Poster at European Society for Medical Oncology (ESMO)LSE:0RISCircio Holding Asa
27/08/202109:17PR Newswire (US)Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO CongressLSE:0RISCircio Holding Asa
18/08/202107:57PR Newswire (US)Targovax ASA: second quarter and first half year 2021 resultsLSE:0RISCircio Holding Asa
16/08/202107:48PR Newswire (US)Targovax to present at upcoming scientific conferencesLSE:0RISCircio Holding Asa
09/08/202107:14PR Newswire (US)Targovax ASA: Invitation to presentation of Targovax's second quarter and first half 2021 results, Wednesday 18 AugustLSE:0RISCircio Holding Asa
01/07/202111:11PR Newswire (US)Targovax ASA appoints Dr Lone Ottesen as Chief Development OfficerLSE:0RISCircio Holding Asa
28/06/202107:43PR Newswire (US)Targovax to present at the 4th Annual Next Gen Immuno-oncology Virtual Congress-US EditionLSE:0RISCircio Holding Asa
10/06/202113:44PR Newswire (US)Targovax's ONCOS-102 mesothelioma 24-month data shows class-leading median overall survivalLSE:0RISCircio Holding Asa
21/05/202107:21PR Newswire (US)Targovax to present at upcoming investor and scientific conferencesLSE:0RISCircio Holding Asa
06/05/202107:20PR Newswire (US)Targovax ASA: First quarter 2021 resultsLSE:0RISCircio Holding Asa
04/03/202116:47PR Newswire (US)Targovax ASA: Registration of share capital increase following exercise of optionsLSE:0RISCircio Holding Asa
01/03/202118:26PR Newswire (US)Targovax ASA: Exercise of options under LTI program and resolution to increase the share capitalLSE:0RISCircio Holding Asa
23/02/202107:16PR Newswire (US)Continued survival benefit in Targovax's ONCOS-102 trial in mesothelioma at the 21-month follow-upLSE:0RISCircio Holding Asa
18/02/202107:43PR Newswire (US)Reminder: Invitation to Targovax's Capital Markets Day 18 February 2021LSE:0RISCircio Holding Asa
15/02/202107:17PR Newswire (US)Targovax receives Fast-Track designation for ONCOS-102LSE:0RISCircio Holding Asa
11/02/202107:44PR Newswire (US)Agenda for Targovax's Capital Markets Day 18 February 2021LSE:0RISCircio Holding Asa
10/02/202107:22PR Newswire (US)Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (...LSE:0RISCircio Holding Asa
06/01/202107:18PR Newswire (US)Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Si...LSE:0RISCircio Holding Asa
15/12/202007:31PR Newswire (US)Targovax ASA: Save the date - Capital Markets Day 2021LSE:0RISCircio Holding Asa
02/12/202009:21PR Newswire (US)Targovax ASA: Invitation to online presentation at 10:00 CET 2 DecemberLSE:0RISCircio Holding Asa
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RIS

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
TEN
Tenaris
BIT
AMP
Amplifon
BIT
PRY
Prysmian
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network